EARLY BREAST CANCER
Clinical trials for EARLY BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new EARLY BREAST CANCER trials appear
Sign up with your email to follow new studies for EARLY BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Mediterranean diet may boost gut health and Well-Being in breast cancer patients
Disease control Recruiting nowThis study looks at whether eating a Mediterranean diet (rich in vegetables, fruits, nuts, fish, and olive oil) can improve gut health, quality of life, and treatment outcomes for women with early breast cancer undergoing chemotherapy. About 105 participants will be randomly assi…
Matched conditions: EARLY BREAST CANCER
Phase: PHASE2 • Sponsor: Esbjerg Hospital - University Hospital of Southern Denmark • Aim: Disease control
Last updated Jun 22, 2026 12:08 UTC
-
Robot-Assisted mastectomy: smaller scars, same safety?
Disease control Recruiting nowThis study is testing a handheld robotic tool called HandX to help surgeons perform a nipple-sparing mastectomy through a single small incision. The goal is to remove breast tissue while keeping the skin and nipple, leading to less scarring and better cosmetic results. About 15 w…
Matched conditions: EARLY BREAST CANCER
Phase: NA • Sponsor: Vasileios Kalles • Aim: Disease control
Last updated Jun 22, 2026 12:06 UTC
-
Older women with Low-Risk breast cancer may avoid unnecessary surgery
Disease control Recruiting nowThis study looks at whether women over 59 with a specific low-risk type of early breast cancer (luminal A) can safely skip sentinel lymph node biopsy, a standard surgical procedure to check if cancer has spread. The goal is to see if avoiding this biopsy leads to the same low rat…
Matched conditions: EARLY BREAST CANCER
Phase: NA • Sponsor: N.N. Petrov National Medical Research Center of Oncology • Aim: Disease control
Last updated Jun 22, 2026 12:05 UTC
-
MRI-Guided chemo reduction trial aims to spare TNBC patients from toxic drugs
Disease control Recruiting nowThis study tests whether MRI scans can identify triple-negative breast cancer patients who respond well to initial chemotherapy and immunotherapy, allowing them to skip the second, more toxic phase of treatment. About 54 participants will receive four cycles of a chemo-immunother…
Matched conditions: EARLY BREAST CANCER
Phase: PHASE2 • Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New drug combo aims to stop breast cancer recurrence in High-Risk patients
Disease control Recruiting nowThis study tests whether adding ribociclib to standard hormone therapy can help prevent breast cancer from returning in people with high-risk, hormone-receptor-positive, HER2-negative early breast cancer. About 1,400 adults will receive the combination treatment for several years…
Matched conditions: EARLY BREAST CANCER
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 05, 2026 12:07 UTC
-
New study: app and nurse calls ease chemo side effects for cancer patients
Symptom relief Recruiting nowThis study tests whether a smartphone app that lets cancer patients report their symptoms, combined with regular calls from a specially trained nurse, can help them better manage chemotherapy side effects and improve their quality of life. The study includes 414 adults with early…
Matched conditions: EARLY BREAST CANCER
Phase: NA • Sponsor: Ulsan University Hospital • Aim: Symptom relief
Last updated Jun 15, 2026 19:05 UTC
-
Scientists dive inside breast cancer cells to uncover hidden clues
Knowledge-focused Recruiting nowThis study looks at the inner workings of breast cancer cells, focusing on fat droplets and proteins, in 1,050 people with early or metastatic breast cancer. Researchers will take tumor samples and analyze them in the lab to see how different subtypes differ. The goal is to learn…
Matched conditions: EARLY BREAST CANCER
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:59 UTC
-
Breast cancer adherence study aims to uncover why patients stop taking Life-Saving pills
Knowledge-focused Recruiting nowThis study tracks 319 women with early-stage, hormone receptor-positive, HER2-negative breast cancer to see how well they take their prescribed aromatase inhibitors, with or without the added drug abemaciclib. Researchers will measure adherence using pill counts and questionnaire…
Matched conditions: EARLY BREAST CANCER
Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:58 UTC